For example, the dysregulation of Mef2d has been implicated in conditions such as dilated cardiomyopathy and cardiac hypertrophy, reflecting shared inflammatory and metabolic axes [56,57]. This evidence concerns the gene MEF2D and cardiac hypertrophy.